Balanced news tone
News Sentiment
600518 sentiment intelligence
Kangmei Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
71/100 classification confidence.
directly relevant articles
high-authority source matches
+5.5% over one week, -4.3% over four weeks, trend inactive, and below fair value.
Price to earnings forward of Kangmei Pharmaceutical Co., Ltd Class A – SSE:600518
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to earnings forward of Kangmei Pharmaceutical Co., Ltd Class A – SSE:600518
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 17:37
- Source
- TradingView
* ST Kangmei (600518.SH): Shennong intends to acquire 25.31% of the company's equity or become a controlling shareholder for no more than 5.419 billion yuan.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Dec 2021 08:00
- Source
- Moomoo
Kangmei Ordered to Pay $385 Million to Investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Nov 2021 08:00
- Source
- Caixin Global
Drugmaker Kangmei Seeks Stock Trading Halt After Regulator Confirms It Faked Financial Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2019 07:00
- Source
- Caixin Global